OMX Nordic 40
2 377,71
|
-5,74
|
-0,24 %
|
Analysen zu OMX Nordic 40-Werten
16.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
16.05.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
16.05.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
14.05.25 | A.P. Moeller - Maersk A-S Hold | Deutsche Bank AG | |
12.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
12.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
12.05.25 | Volvo AB Underperform | Bernstein Research | |
12.05.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
09.05.25 | A.P. Moeller - Maersk A-S Underperform | Bernstein Research | |
09.05.25 | ABB Neutral | UBS AG | |
09.05.25 | Novo Nordisk Buy | UBS AG | |
08.05.25 | ABB Sector Perform | RBC Capital Markets | |
08.05.25 | Novo Nordisk Halten | DZ BANK | |
08.05.25 | AstraZeneca Hold | Deutsche Bank AG | |
08.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
08.05.25 | Novo Nordisk Buy | UBS AG | |
07.05.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
07.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
07.05.25 | Novo Nordisk Market-Perform | Bernstein Research | |
07.05.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
07.05.25 | ABB Neutral | Goldman Sachs Group Inc. | |
02.05.25 | Novo Nordisk Buy | UBS AG | |
02.05.25 | Novo Nordisk Market-Perform | Bernstein Research | |
02.05.25 | Novo Nordisk Buy | UBS AG | |
01.05.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
30.04.25 | Novo Nordisk Buy | UBS AG | |
30.04.25 | AstraZeneca Halten | DZ BANK | |
30.04.25 | AstraZeneca Hold | Deutsche Bank AG | |
30.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
29.04.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
29.04.25 | AstraZeneca Outperform | Bernstein Research | |
29.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
29.04.25 | Nokia Buy | Deutsche Bank AG | |
29.04.25 | AstraZeneca Buy | UBS AG | |
28.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
28.04.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
28.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
28.04.25 | Novo Nordisk Buy | UBS AG | |
25.04.25 | A.P. Moeller - Maersk A-S Underweight | JP Morgan Chase & Co. | |
25.04.25 | Nokia Overweight | JP Morgan Chase & Co. |